| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Department of Medicine, University of Florida Shands Cancer Center; 2 Department of Infectious Disease and Pathology, College of Veterinary Medicine and 3 Department of Physiology and Functional Genomics, University of Florida, Gainesville, Florida
Requests for reprints: W. Stratford May, University of Florida Shands Cancer Center, 1376 Mowry Road, Gainesville, FL 32610-3633. Phone: 352-273-8014; Fax: 352-273-8285; E-mail: smay{at}medicine.ufl.edu.
Key Words: Non–receptor protein tyrosine kinase (NRPTK) Kinase of embryonic stem cells (Kos1) Thirty-eight negative kinase1 (Tnk1) Ras Grb2 Spontaneous tumors Loss of heterozygosity (LOH)
Tnk1/Kos1 is a non–receptor protein tyrosine kinase implicated in negatively regulating cell growth in a mechanism requiring its intrinsic catalytic activity. Tnk1/Kos1 null mice were created by homologous recombination by deleting the catalytic domain. Both Tnk1+/– and Tnk1–/– mice develop spontaneous tumors, including lymphomas and carcinomas, at high rates [27% (14 of 52) and 43% (12 of 28), respectively]. Tnk1/Kos1 expression is silenced in tumors that develop in Tnk1+/– mice but not in adjacent uninvolved tissue, and silencing occurs in association with Tnk1 promoter hypermethylation. Tissues and murine embryonic fibroblasts derived from Tnk1/Kos1-null mice exhibit proportionally higher levels of basal and epidermal growth factor–stimulated Ras activation that results from increased Ras-guanine exchange factor (GEF) activity. Mechanistically, Tnk1/Kos1 can directly tyrosine phosphorylate growth factor receptor binding protein 2 (Grb2), which promotes disruption of the Grb2-Sos1 complex that mediates growth factor–induced Ras activation, providing dynamic regulation of Ras GEF activity with suppression of Ras. Thus, Tnk1/Kos1 is a tumor suppressor that functions to down-regulate Ras activity. [Cancer Res 2008;68(21):8723–32]
This article has been cited by other articles:
![]() |
A. M. Ashique, Y. Choe, M. Karlen, S. R. May, K. Phamluong, M. J. Solloway, J. Ericson, and A. S. Peterson The Rfx4 Transcription Factor Modulates Shh Signaling by Regional Control of Ciliogenesis Sci. Signal., November 3, 2009; 2(95): ra70 - ra70. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |